4/25
10:04 pm
gild
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/25
07:49 pm
gild
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
4/25
04:32 pm
gild
Gilead Sciences Announces First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Gilead Sciences Announces First Quarter 2024 Financial Results [Yahoo! Finance]
4/25
04:02 pm
gild
Gilead Sciences Announces First Quarter 2024 Financial Results
Low
Report
Gilead Sciences Announces First Quarter 2024 Financial Results
4/25
02:44 pm
gild
Built environment thought leaders discuss pathways to circular economy at Tarkett's third annual Circularity Summit [Yahoo! Finance]
Low
Report
Built environment thought leaders discuss pathways to circular economy at Tarkett's third annual Circularity Summit [Yahoo! Finance]
4/24
05:39 pm
gild
Notable earnings after Thursday's close [Seeking Alpha]
Medium
Report
Notable earnings after Thursday's close [Seeking Alpha]
4/24
01:42 pm
gild
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at HSBC Holdings plc from a "reduce" rating to a "hold" rating. They now have a $69.00 price target on the stock.
Low
Report
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at HSBC Holdings plc from a "reduce" rating to a "hold" rating. They now have a $69.00 price target on the stock.
4/23
09:32 am
gild
Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? [Seeking Alpha]
Low
Report
Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? [Seeking Alpha]
4/22
03:58 pm
gild
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect? [Yahoo! Finance]
Neutral
Report
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect? [Yahoo! Finance]
4/22
10:56 am
gild
Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics [Yahoo! Finance]
Low
Report
Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics [Yahoo! Finance]
4/19
11:01 pm
gild
Gilead Sciences, Inc. (NASDAQ: GILD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Gilead Sciences, Inc. (NASDAQ: GILD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
4/19
07:06 pm
gild
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]
Low
Report
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]
4/19
11:23 am
gild
Gilead Sciences, Inc. (NASDAQ: GILD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $105.00 price target on the stock.
Low
Report
Gilead Sciences, Inc. (NASDAQ: GILD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $105.00 price target on the stock.
4/19
09:19 am
gild
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure [Yahoo! Finance]
Low
Report
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure [Yahoo! Finance]
4/19
09:10 am
gild
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure [Financial Post (Toronto, Ontario, Canada)]
Low
Report
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure [Financial Post (Toronto, Ontario, Canada)]
4/18
09:13 pm
gild
Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program
Low
Report
Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program
4/18
07:54 pm
gild
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]
Low
Report
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]
4/18
06:43 pm
gild
US FDA mandates label updates on CAR-T cancer therapies [Yahoo! Finance]
Low
Report
US FDA mandates label updates on CAR-T cancer therapies [Yahoo! Finance]
4/18
02:09 pm
gild
Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72% [Yahoo! Finance]
Low
Report
Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72% [Yahoo! Finance]
4/18
01:52 pm
gild
Gilead Sciences Publishes 2023 ESG Impact Report [Yahoo! Finance]
Low
Report
Gilead Sciences Publishes 2023 ESG Impact Report [Yahoo! Finance]
4/18
12:09 pm
gild
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]
Low
Report
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]
4/18
08:04 am
gild
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at UBS Group AG from $81.00 to $75.00. They now have a "neutral" rating on the stock.
Low
Report
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at UBS Group AG from $81.00 to $75.00. They now have a "neutral" rating on the stock.
4/17
05:35 am
gild
Gilead Sciences h?p tác cùng Liên Minh Viêm Gan Th? Gi?i và các chuyên gia d? trao gi?i thu?ng All4Liver tr? giá 4 tri?u dô la M? cho m?c tiêu lo?i b? viêm gan virus vào nam 2030, bao g?m hai sáng ki?n d?i m?i t?i châu Á.
Low
Report
Gilead Sciences h?p tác cùng Liên Minh Viêm Gan Th? Gi?i và các chuyên gia d? trao gi?i thu?ng All4Liver tr? giá 4 tri?u dô la M? cho m?c tiêu lo?i b? viêm gan virus vào nam 2030, bao g?m hai sáng ki?n d?i m?i t?i châu Á.
4/17
02:09 am
gild
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA [Yahoo! Finance]
Low
Report
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA [Yahoo! Finance]
4/17
02:03 am
gild
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
Low
Report
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA